Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 56,400 shares changing hands.
Resverlogix Trading Up 5.0%
The business’s 50 day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.10. The stock has a market cap of C$33.28 million, a P/E ratio of -5.25 and a beta of 0.41. The company has a quick ratio of 0.04, a current ratio of 0.03 and a debt-to-equity ratio of -83.11.
Resverlogix (TSE:RVX – Get Free Report) last issued its quarterly earnings results on Friday, May 15th. The biotechnology company reported C$0.01 EPS for the quarter. As a group, analysts expect that Resverlogix Corp. will post -0.22 EPS for the current year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
